Table 3.

Analysis of progression-free survival using Kaplan–Meier method (FAS, dose-expansion part).

	All patients n = 35
Number of events, n (%)	29 (82.9)
Progression	27 (77.1)
Death	2 (5.7)
Number of censoring, n (%)	6 (17.1)
Percentiles (95% CI) (months)
25th	1.9 (1.7–1.9)
50th	3.5 (1.9–5.4)
75th	5.5 (3.7–11.4)
% Event-free probability estimates (95% CI)
2 months	57.4 (38.8–72.2)
4 months	37.3 (20.8–53.8)
6 months	22.4 (9.4–38.7)
8 months	18.6 (7.0–34.6)
11 months	11.2 (2.9–25.8)

CI confidence interval, FAS full-analysis set.